PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33524379-0	2021	RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson"s disease through the ASK1/JNK signalling pathway.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	37-41	receptor interacting serine/threonine kinase 1	Homo sapiens	0-5	
33524379-0	2021	RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson"s disease through the ASK1/JNK signalling pathway.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	37-41	M-phase phosphoprotein 6	Homo sapiens	32-35	
33524379-0	2021	RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson"s disease through the ASK1/JNK signalling pathway.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	37-41	mitogen-activated protein kinase kinase kinase 5	Homo sapiens	82-86	
33524379-0	2021	RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson"s disease through the ASK1/JNK signalling pathway.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	37-41	mitogen-activated protein kinase 8	Homo sapiens	87-90	
33524379-4	2021	The results showed that RIPK1 was high expressed and activated in MPP+-treated SH-SY5Y cells and MPTP-induced PD mice.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	97-101	receptor interacting serine/threonine kinase 1	Homo sapiens	24-29	
33524379-5	2021	Overexpression of RIPK1 facilitated cell apoptosis, necrosis, inflammation response, ROS production and mitochondrial dysfunction in MPP+- treated SH-SY5Y cells, while the RIPK1 inhibitor Nec-1s has an opposite effect.	ros	85-88	receptor interacting serine/threonine kinase 1	Homo sapiens	18-23